Gene Therapy and Stem Cell Applications in Bone Regeneration

Bone regeneration combines advances in molecular biology, cell therapy and biomaterials to repair critical bone defects that cannot heal spontaneously. Gene therapy enables targeted delivery of osteogenic factors by introducing genetic constructs into cells or tissues, thereby stimulating sustained production of proteins that direct bone formation. Stem cell approaches, particularly using mesenchymal stem cells (MSCs), provide a reservoir of progenitor cells capable of differentiating into osteoblasts under appropriate biochemical and mechanical cues. Integration of these strategies with three-dimensional scaffolds or injectable matrices affords spatial control, mechanical support and controlled release of bioactive signals. Progress in viral and non-viral vectors, chemically modified mRNA and tissue-engineered constructs has lowered immunogenicity and improved transfection efficiency. Clinically, such approaches promise to reduce the need for autograft harvesting, diminish donor-site morbidity and accelerate healing in fractures, non-unions and large segmental defects. Recent innovations focus on synergistic osteogenic and angiogenic programmes, enabling vascularised bone repair, while scaffold optimisation and minimally invasive delivery pave the way for translation into orthopaedic and maxillofacial practice.

Research from Nature Portfolio

Recent studies have demonstrated that co-delivery of chemically modified mRNAs encoding bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor-A (VEGF-A) within a collagen scaffold can synchronise osteogenic and angiogenic pathways. Bone marrow stem cells treated with these modRNAs showed enhanced expression of osteogenic markers and formation of mineralised matrix in vitro. In an in vivo cranial defect model, scaffolds seeded with modRNA-engineered cells achieved superior bone fill and neovascularisation compared with single-factor or untreated controls. This work highlights the potential of non-viral, transient gene programmes coupled with biomaterials to promote robust and spatially organised bone repair without permanent genome integration.

Gene Therapy and Stem Cell Applications in Bone Regeneration publication trend

The graph below shows the total number of articles in gene therapy and stem cell applications in bone regeneration across all publications each year (not limited to Nature Index journals).

Technical terms

Gene therapy: introduction of nucleic acids into cells to modulate expression of therapeutic proteins.

Mesenchymal stem cells (MSCs): multipotent stromal cells capable of differentiating into bone, cartilage and fat lineages.

Bone morphogenetic proteins (BMPs): a family of growth factors that induce osteogenesis by activating specific cell surface receptors.

Viral vector: a virus-based delivery system engineered to transport genetic material into host cells.

Non-viral vector: a synthetic carrier, such as lipoplex or polymeric nanoparticle, used to deliver nucleic acids without viral components.

Chemically modified mRNA (modRNA): synthetic messenger RNA with nucleotide modifications that enhance stability and reduce immunogenicity.

Scaffold: a three-dimensional biomaterial framework providing mechanical support and a surface for cell attachment and tissue growth.

Osteogenesis: the process of new bone formation by differentiation of progenitor cells into osteoblasts.

Angiogenesis: the formation of new blood vessels from pre-existing vasculature, essential for nutrient supply in regenerating bone.

References

1. BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways. Communications Biology (2021).
2. Adenovirus-Based Gene Therapy for Bone Regeneration: A Comparative Analysis of In Vivo and Ex Vivo BMP2 Gene Delivery. Cells (2023).
3. Mineral coated microparticles doped with fluoride and complexed with mRNA prolong transfection in fracture healing. Frontiers in Bioengineering and Biotechnology (2024).
4. Research progress of gene therapy combined with tissue engineering to promote bone regeneration. APL Bioengineering (2024).